Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Schriock

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Western Journal of Medicine|April 1, 1985
Polycystic ovarian diseaseE Schriock, M C Martin, R B Jaffe
Fertility and Sterility|November 1, 1985
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)E Schriock, S E Monroe, M Henzl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1986
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin)S E Monroe, Z Blumenfeld, J L Andreyko, et al.
American Journal of Obstetrics and Gynecology|September 1, 1985
Gynecologic masses: value of magnetic resonance imagingH Hricak, C Lacey, E Schriock, et al.
Fertility and Sterility|March 1, 1985
Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycleS E Monroe, M R Henzl, M C Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)P W Speiser, N Laforgia, K Kato, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Western Journal of Medicine|April 1, 1985
Polycystic ovarian diseaseE Schriock, M C Martin, R B Jaffe
Fertility and Sterility|November 1, 1985
Treatment of endometriosis with a potent agonist of gonadotropin-releasing hormone (nafarelin)E Schriock, S E Monroe, M Henzl, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1986
Dose-dependent inhibition of pituitary-ovarian function during administration of a gonadotropin-releasing hormone agonistic analog (nafarelin)S E Monroe, Z Blumenfeld, J L Andreyko, et al.
American Journal of Obstetrics and Gynecology|September 1, 1985
Gynecologic masses: value of magnetic resonance imagingH Hricak, C Lacey, E Schriock, et al.
Fertility and Sterility|March 1, 1985
Ablation of folliculogenesis in women by a single dose of gonadotropin-releasing hormone agonist: significance of time in cycleS E Monroe, M R Henzl, M C Martin, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1990
First trimester prenatal treatment and molecular genetic diagnosis of congenital adrenal hyperplasia (21-hydroxylase deficiency)P W Speiser, N Laforgia, K Kato, et al.
Pageof 1